Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / United Kingdom

Lloydspharmacy's Adoption Of Intelligent Medicine Aligns With Its Focus On Consumerised Healthcare

January 2012 | Industry Trend Analysis

BMI View: The design of drugs - both visual and in terms of their administration - will become an increasingly important facet of the drug development process, as the value of a medicine has to be communicated to both patients and healthcare professionals. Patient expectations will rise as the shift towards taking greater responsibility for personal healthcare plays out, driven by the increasing individuality of modern drugs.

To read the full article, please choose one of the following options:

Subcribers please log in

Western Europe InsightWestern Europe Channels Western Europe Countries